Related Experiment Video
Updated: Mar 17, 2026

06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
34.1K
Sensitivity and specificity of executive function tests for Alzheimer's disease
Shu-Fen Huang1, Ching-Kuan Liu2, Chiung-Chih Chang3
1a Department of Rehabilitation Medicine, Ministry of Health and Welfare Pingtung Hospital , Pingtung , Taiwan.
Applied Neuropsychology. Adult
|July 16, 2016
Summary
Early Alzheimer's disease (AD) impairs executive function (EF). Category fluency and Tower of London tests effectively identify these changes, aiding early diagnosis and intervention for better outcomes.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Gerontology
Background:
- Executive function (EF) decline is an early indicator in Alzheimer's disease (AD).
- Limited understanding exists regarding the efficacy of traditional EF tests in detecting early AD-related cognitive changes.
- Early diagnosis and intervention are crucial for improving functional outcomes in individuals with AD.
Purpose of the Study:
- To identify specific EF measures that best differentiate mild AD from normal aging.
- To evaluate the diagnostic accuracy of various EF tests in mild AD.
- To determine the utility of EF tests for early AD detection.
Main Methods:
- Thirty-one patients with mild AD and 31 age-matched controls participated.
- Seven distinct EF tests were administered to all participants.
- Statistical analyses, including regression modeling and AUC calculation, were employed.
Main Results:
- Significant differences between AD patients and controls were found in six out of seven EF tests.
- Category fluency and the Tower of London test demonstrated the highest accuracy in discriminating between groups.
- A regression model combining these two tests yielded a high Area Under the Curve (AUC) of 0.90.
Conclusions:
- Most tested EF measures are valid for assessing mild cognitive disturbances associated with AD.
- Category fluency and the Tower of London test are particularly effective for screening or in-depth evaluation of EF in mild AD.
- These findings support the use of specific EF tests for identifying AD-related cognitive impairments.
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Sensitivity, Specificity, and Predicted Value
1.7K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
1.7K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K

